Skip to content

The Effectiveness of Shenfuqingpi Decoction in the Treatment of Septic Shock: A Randomized Double-blind Controlled Trial

The Effectiveness of Shenfuqingpi Decoction in the Treatment of Septic Shock: A Randomized Double-blind Controlled Trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088049
Enrollment
Unknown
Registered
2024-08-09
Start date
2024-03-25
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic shock

Interventions

Control group:Based on the Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021, treatment options for septic shock, combined Shenfu Tang granules
Treatment group:Based on the Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021, treatment options for septic shock, combined Shenfuqingpi Tang granules

Sponsors

ShuGuang hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Septic shock patients admitted to ICU; 2. Aged between 18 and 85; 3. TCM syndrome differentiation type is outburst of yang or internal closure and external withdrawal; 4. Sign the informed consent in a sober and voluntary manner, and complete the visit and follow-up as required. If you are unable to sign the informed consent and complete the questionnaire by yourself, you can have your legal representative or guardian act on your behalf.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating female patients; 2. Patients with acute gastrointestinal injury; 3. Patients with a history of malignant tumors; 4. Patients considered unsuitable for this study by other investigators.

Design outcomes

Primary

MeasureTime frame
Shock correction ratio;

Secondary

MeasureTime frame
Use of vasoactive agents;Blood lactic acid;Capillary refill time;White blood cell;Heparin-binding protein;Sequential organ failure score;Percentage of neutrophils;Lymphocyte count;Hemoglobin;Blood platelet;Procalcitonin;IL-6;

Countries

China

Contacts

Public ContactZHOU Zhen

ShuGuang hospital affiliated to Shanghai University of Traditional Chinese Medicine

zhouz.milk@outlook.com+86 136 5162 8239

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026